1
项与 Quadrivalent Influenza mRNA Vaccine(Sanofi Pasteur) 相关的临床试验Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older
The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of up to 3 dose levels of Quadrivalent Influenza mRNA Vaccine MRT5410 compared to an active control (QIV SD, QIV HD [adults ≥ 65 years of age only], or RIV4) in adults 18 years of age and older.
100 项与 Quadrivalent Influenza mRNA Vaccine(Sanofi Pasteur) 相关的临床结果
100 项与 Quadrivalent Influenza mRNA Vaccine(Sanofi Pasteur) 相关的转化医学
100 项与 Quadrivalent Influenza mRNA Vaccine(Sanofi Pasteur) 相关的专利(医药)
100 项与 Quadrivalent Influenza mRNA Vaccine(Sanofi Pasteur) 相关的药物交易